Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.

0 avis

Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.

Archive ouverte

Edité par CCSD ; American Chemical Society -

Monoamine oxidases (MAOs) are involved in various psychiatric and neurodegenerative disorders; hence, MAO inhibitors are useful agents in the therapy of Parkinson's disease, Alzheimer's dementia, and depression syndrome. Herein we report a novel series of 3-(1H-pyrrol-3-yl)-2-oxazolidinones 3-7 as reversible, highly potent and selective anti-MAO-A agents. In particular, 4b, 5b, and 4c showed a K(i-MAO-A) of 0.6, 0.8, and 1 nM, respectively, 4c being 200000-fold selective for MAO-A with respect to MAO-B.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Polyamine catabolism: target for antiproliferative therapies in animals and stress tolerance strategies in plants.

Archive ouverte | Tavladoraki, Paraskevi | CCSD

International audience. Metabolism of polyamines spermidine and spermine, and their diamine precursor, putrescine, has been a target for antineoplastic therapy since these naturally occurring alkyl amines were found...

Combined HAT/EZH2 modulation leads to cancer-selective cell death

Archive ouverte | Petraglia, Francesca | CCSD

International audience. Epigenetic alterations have been associated with both pathogenesis and progression of cancer. By screening of library compounds, we identified a novel hybrid epi-drug MC2884, a HAT/EZH2 inhib...

Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells.

Archive ouverte | Valente, Sergio | CCSD

International audience. Chemical manipulations undertaken on some bis(bromo- and dibromo-phenol) compounds previously reported by us as wide-spectrum epigenetic inhibitors let us to identify bis (bromo- and dibromo-...

Chargement des enrichissements...